$266 Million is the total value of Sio Capital Management, LLC's 62 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 73.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CI | Sell | CIGNA CORP | $13,976,000 | -14.0% | 53,034 | -21.8% | 5.25% | -2.4% |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $9,416,000 | -5.0% | 39,959 | -27.7% | 3.54% | +7.8% |
| NTUS | Sell | NATUS MEDICAL INC | $6,258,000 | +24.3% | 190,956 | -0.3% | 2.35% | +41.2% |
| MRUS | Sell | MERUS NV | $1,991,000 | -16.3% | 87,953 | -2.3% | 0.75% | -5.0% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $1,639,000 | -6.3% | 555,610 | -1.2% | 0.62% | +6.4% |
| MBRX | Sell | MOLECULIN BIOTECH INC | $1,503,000 | -18.8% | 1,036,853 | -0.4% | 0.56% | -7.8% |
| ALBO | Sell | ALBIREO PHARMA INC | $1,163,000 | -73.0% | 58,556 | -59.5% | 0.44% | -69.4% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $498,000 | -84.6% | 16,368 | -84.5% | 0.19% | -82.5% |
| LOGC | Exit | LOGICBIO THERAPEUTICS INC | $0 | – | -182,630 | -100.0% | -0.04% | – |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -9,168 | -100.0% | -0.05% | – |
| KOD | Exit | KODIAK SCIENCES INCcall | $0 | – | -30,600 | -100.0% | -0.08% | – |
| AYLA | Exit | AYALA PHARMACEUTICALS INC | $0 | – | -60,220 | -100.0% | -0.08% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -44,400 | -100.0% | -0.13% | – |
| AVAH | Exit | AVEANNA HEALTHCARE HOLDINGS INC | $0 | – | -131,812 | -100.0% | -0.15% | – |
| SYRS | Exit | SYROS PHARMACEUTICALS INC | $0 | – | -902,907 | -100.0% | -0.36% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -48,768 | -100.0% | -0.52% | – |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -161,285 | -100.0% | -1.18% | – |
| NKTR | Exit | NEKTAR THERAPEUTICSput | $0 | – | -693,700 | -100.0% | -1.24% | – |
| CRIS | Exit | CURIS INC | $0 | – | -1,915,460 | -100.0% | -1.51% | – |
| MEDP | Exit | MEDPACE HOLDINGS INC | $0 | – | -28,400 | -100.0% | -1.54% | – |
| VAPO | Exit | VAPOTHERM INC | $0 | – | -353,006 | -100.0% | -1.62% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -175,568 | -100.0% | -2.15% | – |
| VREX | Exit | VAREX IMAGING CORP | $0 | – | -315,486 | -100.0% | -2.22% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -146,696 | -100.0% | -3.01% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -34,501 | -100.0% | -3.49% | – |
| LH | Exit | LABORATORY CORPORATION OF AMERICA HOLDINGS | $0 | – | -49,328 | -100.0% | -4.30% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -58,500 | -100.0% | -5.05% | – |
| SNY | Exit | SANOFI SAsponsored adr | $0 | – | -300,000 | -100.0% | -5.10% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -195,160 | -100.0% | -5.30% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCput | $0 | – | -133,000 | -100.0% | -11.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.